148 related articles for article (PubMed ID: 18200497)
1. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.
Pello OM; Martínez-Muñoz L; Parrillas V; Serrano A; Rodríguez-Frade JM; Toro MJ; Lucas P; Monterrubio M; Martínez-A C; Mellado M
Eur J Immunol; 2008 Feb; 38(2):537-49. PubMed ID: 18200497
[TBL] [Abstract][Full Text] [Related]
2. Slamming the DOR on chemokine receptor signaling: heterodimerization silences ligand-occupied CXCR4 and delta-opioid receptors.
Hereld D; Jin T
Eur J Immunol; 2008 Feb; 38(2):334-7. PubMed ID: 18203136
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
5. Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors.
He X; Fang L; Wang J; Yi Y; Zhang S; Xie X
Cancer Res; 2008 Nov; 68(21):8678-86. PubMed ID: 18974109
[TBL] [Abstract][Full Text] [Related]
6. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells.
Zhang L; Tetrault J; Wang W; Loh HH; Law PY
Mol Pharmacol; 2006 Jun; 69(6):1810-9. PubMed ID: 16525132
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.
Isik N; Hereld D; Jin T
PLoS One; 2008; 3(10):e3424. PubMed ID: 18923649
[TBL] [Abstract][Full Text] [Related]
9. Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands: adhesion molecules involved and implications for multiple sclerosis pathogenesis.
Poggi A; Zancolli M; Catellani S; Borsellino G; Battistini L; Zocchi MR
Ann N Y Acad Sci; 2007 Jun; 1107():68-78. PubMed ID: 17804534
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
Lee Y; Kim JM; Lee EJ
J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cDNA and genomic sequences encoding a canine chemokine receptor, CXCR4 and its ligand CXCL12.
Tsuchida S; Kagi A; Takahashi T
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):219-25. PubMed ID: 17316828
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
Liu KK; Dorovini-Zis K
J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
Bodart V; Anastassov V; Darkes MC; Idzan SR; Labrecque J; Lau G; Mosi RM; Neff KS; Nelson KL; Ruzek MC; Patel K; Santucci Z; Scarborough R; Wong RS; Bridger GJ; Macfarland RT; Fricker SP
Biochem Pharmacol; 2009 Oct; 78(8):993-1000. PubMed ID: 19540208
[TBL] [Abstract][Full Text] [Related]
14. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
Heiss A; Ammer H; Eisinger DA
Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
[TBL] [Abstract][Full Text] [Related]
15. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells.
Horn J; Wang X; Reichardt P; Stradal TE; Warnecke N; Simeoni L; Gunzer M; Yablonski D; Schraven B; Kliche S
J Immunol; 2009 Nov; 183(9):5756-67. PubMed ID: 19812192
[TBL] [Abstract][Full Text] [Related]
16. Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells.
Bénard A; Boué J; Chapey E; Jaume M; Gomes B; Dietrich G
J Neuroimmunol; 2008 Jun; 197(1):21-8. PubMed ID: 18486241
[TBL] [Abstract][Full Text] [Related]
17. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
Szabo I; Chen XH; Xin L; Adler MW; Howard OM; Oppenheim JJ; Rogers TJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10276-81. PubMed ID: 12130663
[TBL] [Abstract][Full Text] [Related]
18. Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.
Våbenø J; Nikiforovich GV; Marshall GR
Chem Biol Drug Des; 2006 May; 67(5):346-54. PubMed ID: 16784459
[TBL] [Abstract][Full Text] [Related]
19. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
Chong BF; Mohan C
Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
